Ionis Pharmaceuticals Statistics
Total Valuation
IONS has a market cap or net worth of $4.51 billion. The enterprise value is $4.17 billion.
Important Dates
The next confirmed earnings date is Wednesday, April 30, 2025, before market open.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IONS has 158.96 million shares outstanding. The number of shares has increased by 4.42% in one year.
| Current Share Class | 158.96M |
| Shares Outstanding | 158.96M |
| Shares Change (YoY) | +4.42% |
| Shares Change (QoQ) | +6.33% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 98.14% |
| Float | 157.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.02 |
| Forward PS | 6.80 |
| PB Ratio | 7.62 |
| P/TBV Ratio | 7.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.47, with a Debt / Equity ratio of 3.33.
| Current Ratio | 8.47 |
| Quick Ratio | 7.74 |
| Debt / Equity | 3.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.25 |
Financial Efficiency
Return on equity (ROE) is -93.10% and return on invested capital (ROIC) is -12.12%.
| Return on Equity (ROE) | -93.10% |
| Return on Assets (ROA) | -9.91% |
| Return on Invested Capital (ROIC) | -12.12% |
| Return on Capital Employed (ROCE) | -17.63% |
| Revenue Per Employee | $659,624 |
| Profits Per Employee | -$424,600 |
| Employee Count | 1,069 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 91.49 |
Taxes
| Income Tax | -6.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.82% in the last 52 weeks. The beta is 0.29, so IONS's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -31.82% |
| 50-Day Moving Average | 31.15 |
| 200-Day Moving Average | 38.24 |
| Relative Strength Index (RSI) | 44.54 |
| Average Volume (20 Days) | 1,981,713 |
Short Selling Information
The latest short interest is 13.34 million, so 8.39% of the outstanding shares have been sold short.
| Short Interest | 13.34M |
| Short Previous Month | 12.81M |
| Short % of Shares Out | 8.39% |
| Short % of Float | 8.46% |
| Short Ratio (days to cover) | 8.41 |
Income Statement
In the last 12 months, IONS had revenue of $705.14 million and -$453.90 million in losses. Loss per share was -$3.04.
| Revenue | 705.14M |
| Gross Profit | -207.61M |
| Operating Income | -475.08M |
| Pretax Income | -352.50M |
| Net Income | -453.90M |
| EBITDA | -463.13M |
| EBIT | -475.08M |
| Loss Per Share | -$3.04 |
Full Income StatementBalance Sheet
The company has $2.30 billion in cash and $1.96 billion in debt, giving a net cash position of $344.14 million or $2.16 per share.
| Cash & Cash Equivalents | 2.30B |
| Total Debt | 1.96B |
| Net Cash | 344.14M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 588.35M |
| Book Value Per Share | 3.73 |
| Working Capital | 2.31B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$500.95 million and capital expenditures -$45.28 million, giving a free cash flow of -$546.23 million.
| Operating Cash Flow | -500.95M |
| Capital Expenditures | -45.28M |
| Free Cash Flow | -546.23M |
| FCF Per Share | -$3.44 |
Full Cash Flow StatementMargins
Gross margin is -29.44%, with operating and profit margins of -67.37% and -64.37%.
| Gross Margin | -29.44% |
| Operating Margin | -67.37% |
| Pretax Margin | -65.25% |
| Profit Margin | -64.37% |
| EBITDA Margin | -65.68% |
| EBIT Margin | -67.37% |
| FCF Margin | n/a |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.42% |
| Shareholder Yield | n/a |
| Earnings Yield | -10.05% |
| FCF Yield | -12.10% |
Dividend DetailsAnalyst Forecast
The average price target for IONS is $57.00, which is 101.27% higher than the current price. The consensus rating is "Buy".
| Price Target | $57.00 |
| Price Target Difference | 101.27% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 25.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IONS has an Altman Z-Score of 1.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.18 |
| Piotroski F-Score | 1 |